5,149 Shares in Exponent, Inc. $EXPO Purchased by Bayforest Capital Ltd

Key Points

• Bayforest Capital Ltd acquired 5,149 shares of Exponent, Inc. for approximately $417,000 during the first quarter, as indicated by their recent SEC filing.
• Exponent announced a quarterly dividend of $0.30 per share, with an annualized yield of 1.7%, payable on September 19th.
• Exponent, Inc. reported $0.52 earnings per share for the last quarter, exceeding analysts' expectations, and had a net margin of 18.35%.

Bayforest Capital Ltd acquired a new stake in shares of Exponent, Inc. (NASDAQ:EXPO - Free Report) during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 5,149 shares of the business services provider's stock, valued at approximately $417,000.

Several other institutional investors have also modified their holdings of EXPO. United Services Automobile Association bought a new position in shares of Exponent during the 1st quarter valued at approximately $270,000. Caxton Associates LLP bought a new position in Exponent during the first quarter valued at $634,000. Millennium Management LLC raised its stake in shares of Exponent by 543.1% in the first quarter. Millennium Management LLC now owns 305,230 shares of the business services provider's stock valued at $24,742,000 after acquiring an additional 257,766 shares during the period. Jacobs Levy Equity Management Inc. purchased a new stake in shares of Exponent in the first quarter valued at $12,686,000. Finally, AQR Capital Management LLC lifted its holdings in shares of Exponent by 45.8% in the 1st quarter. AQR Capital Management LLC now owns 83,192 shares of the business services provider's stock worth $6,744,000 after acquiring an additional 26,120 shares during the last quarter. 92.37% of the stock is owned by institutional investors.

Exponent Trading Down 1.9%

Shares of NASDAQ:EXPO opened at $69.66 on Wednesday. The company has a market capitalization of $3.52 billion, a price-to-earnings ratio of 34.83 and a beta of 0.94. Exponent, Inc. has a 12 month low of $63.81 and a 12 month high of $115.75. The firm's 50-day moving average is $72.05 and its 200 day moving average is $76.53.

Exponent (NASDAQ:EXPO - Get Free Report) last announced its quarterly earnings data on Thursday, July 31st. The business services provider reported $0.52 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.48 by $0.04. The business had revenue of $132.87 million during the quarter, compared to the consensus estimate of $130.82 million. Exponent had a net margin of 18.35% and a return on equity of 24.19%. The firm's quarterly revenue was up 7.3% compared to the same quarter last year. During the same quarter last year, the firm earned $0.57 earnings per share. As a group, equities analysts forecast that Exponent, Inc. will post 1.98 EPS for the current fiscal year.

Exponent Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, September 19th. Investors of record on Friday, September 5th will be issued a dividend of $0.30 per share. The ex-dividend date is Friday, September 5th. This represents a $1.20 dividend on an annualized basis and a yield of 1.7%. Exponent's payout ratio is presently 60.00%.

Insider Buying and Selling at Exponent

In related news, CEO Catherine Corrigan sold 4,896 shares of the firm's stock in a transaction dated Thursday, August 14th. The shares were sold at an average price of $71.09, for a total value of $348,056.64. Following the transaction, the chief executive officer owned 81,342 shares of the company's stock, valued at $5,782,602.78. This trade represents a 5.68% decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, VP Joseph Sala sold 1,595 shares of the business's stock in a transaction dated Tuesday, August 12th. The shares were sold at an average price of $70.64, for a total transaction of $112,670.80. The disclosure for this sale can be found here. Corporate insiders own 1.60% of the company's stock.

Exponent Profile

Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering.

Want to see what other hedge funds are holding EXPO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Exponent, Inc. (NASDAQ:EXPO - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.